oleic acid has been researched along with Alzheimer Disease in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (7.69) | 18.2507 |
2000's | 2 (15.38) | 29.6817 |
2010's | 8 (61.54) | 24.3611 |
2020's | 2 (15.38) | 2.80 |
Authors | Studies |
---|---|
Fujino, H; Fukushima, K; Kawamura, J; Kobayashi, H; Kotoura, S; Okabayashi, H; Yamagiwa, N; Yasuda, M | 1 |
Gothwal, A; Lamptey, RNL; Singh, J | 1 |
Fernandes, KJL; Hamilton, LK | 1 |
A Morozova-Roche, L; Huang, Q; Liu, Y; Sun, D; Zhang, C; Zubair Hussain, M | 1 |
Ameen, D; Michniak-Kohn, B | 1 |
Hwang, JS; Jeong, WS; Jun, M; Kim, JY; Lee, J; Youn, K; Yun, EY | 1 |
Aumont, A; Barnabé-Heider, F; Calon, F; Chaurand, P; Dufresne, M; Fernandes, KJ; Furtos, A; Hamilton, LK; Joppé, SE; Parent, M; Petryszyn, S | 1 |
Carvalho, FC; Pereira, GR; Ruela, AL | 1 |
Amtul, Z; Cechetto, DF; Rozmahel, RF; Westaway, D | 1 |
Amtul, Z; Beyreuther, K; Uhrig, M | 1 |
Beher, D; Conde-Knape, K; Liu, Y; Shachter, NS; Shearman, MS; Yang, L | 1 |
Hahn, TR; Jang, HJ; Lee, KH; Paik, YS; Park, YS | 1 |
Dhillon, H; Lovell, MA; Markesbery, WR; Prasad, MR; Yatin, M | 1 |
1 review(s) available for oleic acid and Alzheimer Disease
Article | Year |
---|---|
Neural stem cells and adult brain fatty acid metabolism: Lessons from the 3xTg model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Brain; Disease Models, Animal; Fatty Acids; Humans; Mice, Transgenic; Neural Stem Cells; Neurogenesis; Oleic Acid | 2018 |
12 other study(ies) available for oleic acid and Alzheimer Disease
Article | Year |
---|---|
Phosphatidylcholine-Plasmalogen-Oleic Acid Has Protective Effects against Arachidonic Acid-Induced Cytotoxicity.
Topics: Alzheimer Disease; Arachidonic Acid; Humans; Lecithins; Oleic Acid; Plasmalogens | 2022 |
Multifunctionalized Cationic Chitosan Polymeric Micelles Polyplexed with pVGF for Noninvasive Delivery to the Mouse Brain through the Intranasal Route for Developing Therapeutics for Alzheimer's Disease.
Topics: Administration, Intranasal; Alzheimer Disease; Animals; Brain; Chitosan; Mice; Micelles; Oleic Acid; Polymers | 2023 |
HEWL interacts with dissipated oleic acid micelles, and decreases oleic acid cytotoxicity.
Topics: Alzheimer Disease; Amyloid; Animals; Cell Line; Chickens; Humans; Micelles; Muramidase; Oleic Acid; Protein Aggregation, Pathological; Rats | 2019 |
Development and in vitro evaluation of pressure sensitive adhesive patch for the transdermal delivery of galantamine: Effect of penetration enhancers and crystallization inhibition.
Topics: Adhesives; Administration, Cutaneous; Aged; Alzheimer Disease; Cadaver; Crystallization; Diffusion; Drug Carriers; Drug Evaluation, Preclinical; Drug Liberation; Female; Galantamine; Humans; Limonene; Male; Medication Adherence; Nootropic Agents; Oleic Acid; Permeability; Polymers; Pressure; Skin; Skin Absorption; Spectroscopy, Fourier Transform Infrared; Transdermal Patch | 2019 |
Oleic acid and linoleic acid from Tenebrio molitor larvae inhibit BACE1 activity in vitro: molecular docking studies.
Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Enzyme Inhibitors; Humans; Kinetics; Larva; Linoleic Acid; Molecular Docking Simulation; Oleic Acid; Tenebrio | 2014 |
Aberrant Lipid Metabolism in the Forebrain Niche Suppresses Adult Neural Stem Cell Proliferation in an Animal Model of Alzheimer's Disease.
Topics: Adult Stem Cells; Alzheimer Disease; Animals; Autopsy; Cell Proliferation; Disease Models, Animal; Lipid Metabolism; Mass Spectrometry; Mice; Microarray Analysis; Neural Stem Cells; Oleic Acid; Prosencephalon; Regeneration; Stem Cell Niche | 2015 |
Exploring the Phase Behavior of Monoolein/Oleic Acid/Water Systems for Enhanced Donezepil Administration for Alzheimer Disease Treatment.
Topics: Adhesiveness; Alzheimer Disease; Animals; Chemistry, Pharmaceutical; Cholinesterase Inhibitors; Delayed-Action Preparations; Donepezil; Drug Carriers; Drug Liberation; Glycerides; Humans; In Vitro Techniques; Indans; Intestinal Mucosa; Models, Theoretical; Nanostructures; Oleic Acid; Phase Transition; Piperidines; Solubility; Swine; Water | 2016 |
Oleic acid ameliorates amyloidosis in cellular and mouse models of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Amyloidosis; Animals; Aspartic Acid Endopeptidases; Cells, Cultured; Dietary Fats; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Mice, Neurologic Mutants; Mice, Transgenic; Neuroprotective Agents; Oleic Acid; Peptide Fragments; Plaque, Amyloid; Presenilins | 2011 |
Additive effects of fatty acid mixtures on the levels and ratio of amyloid β40/42 peptides differ from the effects of individual fatty acids.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Animals; Arachidonic Acid; Cells, Cultured; Chlorocebus aethiops; COS Cells; Fatty Acids; Linoleic Acid; Oleic Acid; Peptide Fragments | 2011 |
Fatty acids increase presenilin-1 levels and [gamma]-secretase activity in PSwt-1 cells.
Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; CHO Cells; Cholesterol; Cricetinae; Cricetulus; Endopeptidases; Membrane Proteins; Oleic Acid; Presenilin-1 | 2004 |
Prolyl endopeptidase inhibitory activity of unsaturated fatty acids.
Topics: Alzheimer Disease; Arachidonic Acid; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Humans; Linoleic Acid; Oleic Acid; Prolyl Oligopeptidases; Protease Inhibitors; Serine Endopeptidases | 2006 |
Regional membrane phospholipid alterations in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Arachidonic Acid; Brain; Docosahexaenoic Acids; Fatty Acids; Fatty Acids, Nonesterified; Female; Hippocampus; Humans; Male; Membrane Lipids; Oleic Acid; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylinositols; Phospholipids; Stearic Acids | 1998 |